JAMES BREEN: Open Payments
NPI 1851692800 · DUNEDIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,295 in 48 payments from 11 companies in 2025. Trend: 2023 $1,317 · 2024 $2,036 · 2025 $1,295
Food & beverage: $1,205Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $445 |
| ABBVIE INC. | 9 | $219 |
| GENZYME CORPORATION | 7 | $180 |
| Novartis Pharmaceuticals Corporation | 4 | $118 |
| Amgen Inc. | 4 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Cipher Pharmaceuticals US LLC | 1 | $50 |
| Organon LLC | 2 | $46 |
| Organogenesis Inc. | 1 | $41 |
| Galderma Laboratories, L.P. | 2 | $39 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, OTEZLA, COSENTYX, Natroba, VTAMA, PURAPLY WOUND MATRIX.
Industry payments across FL — which companies pay providers there.
